Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Dementia Management Training Programme for Primary Health Care Providers

1 giugno 2026 aggiornato da: Xinying Lin, Fujian Medical University

Application and Effectiveness of a RE-AIM-Based Dementia Management Competency Training Program for Primary Health Care Providers: A Cluster Randomized Controlled Trial

This study aims to evaluate the effectiveness and implementation outcomes of a dementia management competency training program for primary healthcare workers. A cluster randomized controlled trial will be conducted among primary healthcare institutions in Nanping, Fujian Province, China. Eligible primary health care providers will be recruited from community health service centers and township health centers.Participating institutions will be randomized in a 1:1 ratio to either a structured dementia management training group or a self-directed learning control group. The intervention group will receive a 12-week blended training program, including online learning, an in-person skills workshop, and case-based practice supervision. The control group will receive self-directed online learning materials. Outcomes will be assessed at baseline, immediately after the intervention, and 3 months after the intervention. The primary outcome is the change in dementia knowledge, measured using the Dementia Knowledge Assessment Scale. Secondary outcomes include dementia-related attitudes, dementia management practice competency, self-reported dementia management behaviors, objective screening and referral-related indicators, and implementation outcomes based on the RE-AIM framework.

Panoramica dello studio

Descrizione dettagliata

This study uses a hybrid effectiveness-implementation design integrating a cluster randomized controlled trial and implementation evaluation. The trial will assess the effectiveness of a dementia management competency training program for primary health care providers at both the individual and organizational levels. At the individual level, the study will evaluate the effects of the training on dementia knowledge, attitudes, practice competency, and dementia management-related clinical behaviors. At the organizational level, the study will examine reach, adoption, implementation quality, and maintenance of the training program in real-world primary healthcare settings.The study will be conducted in community health service centers and township health centers in Nanping, Fujian Province, China. Primary healthcare institutions will serve as clusters. Approximately 16 institutions will be recruited and randomized to the intervention or control group at a 1:1 ratio, with approximately 20 primary health care providers recruited from each institution.The intervention group will receive a 12-week structured blended training program named "Hand in Hand Along the Memory Path". During weeks 1-4, participants will complete seven online learning modules, with a total learning duration of approximately 3 hours. At the end of week 4, participants will attend an in-person skills workshop of approximately 2 hours, focusing on standardized use of cognitive screening and assessment tools. During weeks 5-12, participants will take part in online case-based supervision every two weeks and complete practice tasks related to cognitive screening and dementia management.The control group will receive self-directed online learning materials, including the same knowledge module videos and text-based materials. However, the control group will not receive structured learning tasks, case analysis, knowledge tests, demonstration videos, forum-based support, learning reminders, expert support, toolkits, in-person workshops, or case-based supervision.Quantitative data will be collected at baseline, immediately after the intervention, and 3 months after the intervention. Semi-structured interviews will be conducted 3 months after the intervention to explore participants' experiences, implementation barriers and facilitators, and factors affecting maintenance. Quantitative and qualitative findings will be integrated according to the RE-AIM framework.

Tipo di studio

Interventistico

Iscrizione (Stimato)

240

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Adulto
  • Adulto più anziano

Accetta volontari sani

Descrizione

Inclusion Criteria:

Primary healthcare workers aged 18 years or older

Registered healthcare professionals holding a formal license issued by the national health authority

At least 1 year of work experience

Able to access the internet using a computer, tablet, or mobile phone

Currently working in a participating community health service center or township health center

Willing to participate in the study and provide written informed consent

Exclusion Criteria:

Personnel who do not directly participate in patient disease management, including logistics or auxiliary staff

Interns, trainees, or students

Individuals currently participating in other similar dementia training interventions

Individuals planning to leave their current institution within the next 12 months

Individuals who refuse to participate in the study or decline to provide written informed consent

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Altro
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Triplicare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Structured Dementia Management Training Group
Participants in this group will receive a 12-week structured blended dementia management competency training program. The program includes online learning modules, an in-person skills workshop, case-based supervision, and practice tasks designed to improve dementia knowledge, attitudes, practice competency, and dementia management-related behaviors among primary health care providers.
The intervention is a 12-week blended training program. During weeks 1-4, participants will complete seven online modules with a total learning duration of approximately 3 hours. At the end of week 4, participants will attend a 2-hour in-person skills workshop focusing on standardized cognitive screening and assessment. During weeks 5-12, participants will participate in online case-based supervision every two weeks and complete practice tasks, including cognitive screening records and dementia management case records.
Altri nomi:
  • "Hand in Hand on the Memory Journey" dementia management training programme
Comparatore attivo: Self-directed Learning Control Group
Participants in this group will receive self-directed online learning materials related to dementia management. The materials include knowledge module videos and text-based resources but do not include structured learning tasks, case analysis, knowledge tests, demonstration videos, forum-based support, learning reminders, expert support, toolkits, in-person workshops, or case-based supervision.
Participants will be provided with online dementia-related learning materials and will arrange their own learning time and place. No structured completion requirements, assessments, in-person activities, or expert supervision will be provided.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Change in dementia knowledge score
Lasso di tempo: Baseline, immediately after the intervention, and 3 months after the intervention
Dementia knowledge will be measured using the Dementia Knowledge Assessment Scale. The primary outcome is the change in total DKAS score from baseline to immediately after the 12-week intervention. Higher scores indicate greater dementia knowledge.
Baseline, immediately after the intervention, and 3 months after the intervention

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Change in dementia-related attitudes and confidence
Lasso di tempo: Baseline, immediately after the intervention, and 3 months after the intervention
Dementia-related attitudes and confidence will be measured using the General Practitioners' Attitudes and Confidence Scale for Dementia. Higher scores indicate more positive attitudes and greater confidence.
Baseline, immediately after the intervention, and 3 months after the intervention
Change in dementia management practice competency
Lasso di tempo: Baseline, immediately after the intervention, and 3 months after the intervention
Dementia management practice competency was measured using the Dementia Management Practice Competency Scale for Primary Care, which was developed by the research team. Higher scores on the scale indicate greater dementia management practice competency.
Baseline, immediately after the intervention, and 3 months after the intervention
Change in self-reported dementia management-related behaviors
Lasso di tempo: Baseline, immediately after the intervention, and 3 months after the intervention
Participants will report the frequency of dementia management-related behaviors during the past month, including cognitive screening, identification of suspected cognitive impairment, referral recommendation, communication with patients or family members, and dementia-related health education.
Baseline, immediately after the intervention, and 3 months after the intervention
Cognitive screening implementation rate
Lasso di tempo: Baseline, immediately after the intervention, and 3 months after the intervention
The cognitive screening implementation rate will be calculated as the number of patients aged 65 years or older who received cognitive screening divided by the total number of patients aged 65 years or older seen during the same period, multiplied by 100%.
Baseline, immediately after the intervention, and 3 months after the intervention
Referral recommendation documentation rate
Lasso di tempo: Baseline, immediately after the intervention, and 3 months after the intervention
The referral recommendation documentation rate will be calculated as the number of screen-positive patients with documented referral recommendations divided by the total number of screen-positive patients, multiplied by 100%.
Baseline, immediately after the intervention, and 3 months after the intervention

Altre misure di risultato

Misura del risultato
Misura Descrizione
Lasso di tempo
Online course completion rate
Lasso di tempo: Immediately after the intervention
The proportion of intervention group participants who complete all online learning modules.
Immediately after the intervention
In-person workshop attendance rate
Lasso di tempo: Immediately after the intervention
The proportion of intervention group participants who attend the in-person skills workshop.
Immediately after the intervention
Practice task completion rate
Lasso di tempo: Immediately after the intervention
The proportion of intervention group participants who submit the required screening records and case management records.
Immediately after the intervention
Online supervision participation rate
Lasso di tempo: Immediately after the intervention
The number of online supervision sessions attended divided by the number of scheduled supervision sessions.
Immediately after the intervention
Training satisfaction and acceptability
Lasso di tempo: Immediately after the intervention
Satisfaction and acceptability will be assessed using a self-designed questionnaire with Likert-scale items and open-ended questions.
Immediately after the intervention
Institutional maintenance of dementia-related practices
Lasso di tempo: 3 months after the intervention
Institutional maintenance will be assessed using a questionnaire completed by institutional managers, including whether cognitive screening, result explanation, referral recommendation, or related training continues after the intervention.
3 months after the intervention
Barriers and facilitators to implementation and maintenance
Lasso di tempo: 3 months after the intervention
Semi-structured interviews will be conducted with intervention group participants and institutional managers to explore implementation experiences, barriers, facilitators, and suggestions for optimization.
3 months after the intervention

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

15 giugno 2026

Completamento primario (Stimato)

15 settembre 2026

Completamento dello studio (Stimato)

15 dicembre 2026

Date di iscrizione allo studio

Primo inviato

26 maggio 2026

Primo inviato che soddisfa i criteri di controllo qualità

26 maggio 2026

Primo Inserito (Effettivo)

1 giugno 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

3 giugno 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

1 giugno 2026

Ultimo verificato

1 maggio 2026

Maggiori informazioni

Termini relativi a questo studio

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi